MarketVector Indexes™ Licenses the MVIS® Global Bionic Healthcare ESG Index to VanEck Europe

MVIS® Global Bionic Healthcare ESG Index | December 08, 2022 | Read time : 01:00 min

MarketVector Indexes

MarketVector IndexesTM announced the licensing of the MVIS® Global Bionic Healthcare ESG Index to underlie the VanEck Bionic Engineering UCITS ETF.

The MVIS® Global Bionic Healthcare ESG Index includes companies that generate at least 50% of their revenue from medical, dental, or vision-related implants, bioprinting, prosthesis, or preservation of organs and tissue.

We have observed sound growth in the global bionics market which includes a range of niche healthcare solutions from medical implants to prostheses and bioprinting. These innovations in medical technology open new horizons to meet the rising needs of an aging population, significantly improve the quality of life for people with disabilities, and pave the way for the discovery of potentially life-saving treatments. The MVIS® Global Bionic Healthcare ESG Index offers an investable benchmark to track the leading companies in this industry.”

Mirela Stefanova, Manager of Equity Operations at MarketVector

The MVIS® Global Bionic Healthcare ESG Index is weighted by free float market capitalization and reviewed on a quarterly basis. The index is calculated in USD as a price index and a total return net index. Capping factors are applied to avoid overweighting of single index components.

“The proportion of the elderly population is rising and with it the demand for technical solutions such as hearing and visual aids, pacemakers, artificial joints and the like that improve the quality of life in the old age,” says Martijn Rozemuller, CEO at VanEck Europe. “At the same time, increasingly available bionic tools are helping people with chronic diseases such as diabetes or functional disorders.”

About MarketVector Indexes
MarketVector IndexesTM is a regulated Benchmark Administrator in Europe, incorporated in Germany and registered with the Federal Financial Supervisory Authority (BaFin). MarketVector maintains indexes under the MarketVectorTM, MVIS® and BlueStar® names. With a mission to accelerate index innovation globally, MarketVector is best known for its broad suite of Thematic indexes, a long-running expertise in Hard Asset-linked Equity indexes, and its pioneering Digital Asset index family. MarketVector is proud to be in partnership with more than 25 Exchange Traded Product issuers and index fund managers in markets throughout the world, with approximately USD 26.99 billion in assets under management.


Suresh is working on the technology of the future. Giving doctors and patients better ways to manage their health.


Suresh is working on the technology of the future. Giving doctors and patients better ways to manage their health.

Related News


Jefferson Healthcare Enhances Disinfection Program with Germ-zapping Robot

Jefferson Healthcare | February 28, 2023

On February 27, 2023, Jefferson Healthcare informed that it has taken a futuristic step by purchasing a LightStrike Germ-Zapping Robot, which quickly eliminates microscopic pathogens in difficult-to-clean places, at a time when healthcare facilities around the world are searching for effective ways to combat viruses and bacteria that can lurk on high-touch surfaces. The hospital is the first on the peninsula to use a LightStrike robot, and the robot, which has been given the name ELISA, is now hard at work sanitizing patient rooms. With the global emphasis on preventing the spread of COVID-19 and the realization that superbugs are becoming increasingly resistant to cleaning chemicals, medicines, and even hand sanitizers, healthcare facilities are turning to new technology to improve cleaning practices. In healthcare institutions, high-touch surfaces frequently harbor microorganisms such as Clostridioides difficile (C.diff), methicillin-resistant Staphylococcus aureus (MRSA), and vancomycin-resistant Enterococci (VRE). LightStrike Germ-Zapping Robots from Xenex Disinfection Services, the world leader in ultraviolet (UV) disinfection for healthcare institutions, employ pulsed xenon to produce strong bursts of broad-spectrum UV light that kill bacteria and viruses on surfaces. The hospital can disinfect dozens of rooms daily using the UV disinfection robot, which requires no warm-up or cool-down time. Around 45 peer-reviewed studies have proven that LightStrike robot disinfection technology is quite effective. Not only this, but it also kills COVID-19-causing SARS-CoV-2 on surfaces in just two minutes! Most importantly, the robot is operated by facility maintenance personnel and will not displace valuable employees. In Jefferson Healthcare, LightStrike is utilized to disinfect a range of facilities, including patient rooms, isolation rooms, operating rooms, the emergency department, bathrooms, and radiology. About Jefferson Healthcare Jefferson Healthcare provides primary care to over 29,000 inhabitants of eastern Jefferson County on the Olympic Peninsula. The 25-bed critical access hospital in Port Townsend offers top-rated surgical services, a full-service orthopedic clinic, acute and emergency care, oncology and infusion services, advanced diagnostic imaging, a baby-friendly family birth center, physical therapy and rehabilitation, a Coumadin clinic, and sleep medicine. The company also has 8 primary care clinics in Port Ludlow and Quilcene, along with home health as well a hospice agency.

Read More


Norman Regional Health System Signs an Agreement with VisiQuate Inc.

Norman Regional Health System | February 08, 2023

On February 07, 2023, VisiQuate Inc., is one of the industry’s top advanced analytics, intelligent workflow, results-driven, and AI-powered automation service provider, announced Norman Regional Health System, one of the most respected healthcare providers in America, has finalized a multi-year agreement with the company. The leadership of Norman Regional selects VisiQuate Revenue Management Analytics and Denials Management Analytics to optimize financial performance and drive revenue cycle yield enhancements of the organization. In addition, the health system would use the VisiQuate PayFlo solution to standardize and optimize different processes across its end-to-end revenue cycle operations. Director of Patient Financial Services at Norman Regional Health System, Richard Spray, said. "Having on-demand data to identify issues early and resolve them quickly – in addition to the ability to measure and evaluate our processes and productivity – is invaluable. The data analytics platform will help our teams work smarter, which is essential during a time of escalating labor costs and narrowing margins for health systems." (Source: Cision PR Newswire) About Norman Regional Health System Founded in 1946, Norman Regional Health System is a multi-campus system that offers healthcare needs across south central Oklahoma. The company's critical care facility on the Porter Avenue Campus is registered for 219 beds providing a complete range of services to the patients. Norman Regional Moore, which costs $32 million, is a state-of-the-art hospital in Moore, Oklahoma. At Norman Regional Moore, physicians' offices, a place for the community to get together, and a 24-hour-a-day and seven-day-a-week emergency center are available for patients. In addition, the HealthPlex campus at Interstate 35 and Tecumseh Road has Cardiovascular Services, Spine and Orthopedic Surgery, and Women's and Children's Services.

Read More


Veradigm® FollowMyHealth Chosen by KLAS as Most Improved Software Product

Veradigm | February 10, 2023

On February 9, 2023, Veradigm® Inc. announced that Veradigm® FollowMyHealth (previously FollowMyHealth), a top mobile-first patient engagement platform, was recently named Most Improved Software Product by KLAS, a leading healthcare solution evaluator in its 2023 Best in KLAS report. With a mobile-first strategy, Veradigm® FollowMyHealth helps meet patients on their terms and provides patient accessibility through an integrated patient engagement approach. A comprehensive patient care experience fosters collaborative experiences and facilitates access and convenience. In addition, the platform offers a real-time gateway throughout demographic groups and generates immediate and demonstrable value for health systems and independent practices. With increasing healthcare utilization, Veradigm® FollowMyHealth integrates timing and technology to enhance the patient and healthcare provider's experiences. The platform presents a unified view of a patient's record by integrating agnostically across electronic health records (EHRs). Veradigm's Vice President and General Manager of Consumer, Kim Franks, shared, "As a patient engagement leader for over ten years, Veradigm FollowMyHealth is constantly working to improve our solutions and delight both our clients and the patients that depend on us." Kim Franks added, "This recognition by KLAS represents and rewards the focus and hard work our teams put into modernizing and improving our platform. We are proud to be able to provide options to tailor the patient experience in ways that can direct address the needs of our clients in the ever-changing landscape of healthcare." (Source – Business Wire) About Veradigm® Veradigm® is a healthcare technology company founded in 2018 and based in Chicago, Illinois. By combining data-driven clinical insights with actionable tools, the company assists healthcare stakeholders in enhancing care delivery quality, efficiency, and value. It serves people across the healthcare system, including biopharma, health plans, healthcare providers, network partners, and, most importantly, patients. The Veradigm Network consists of a dynamic community of solutions and partners offering advanced insights, technology, and data-driven solutions, all of which collaborate to transform healthcare insightfully.

Read More